The role of hsa‐miR‐193a‐5p as an important factor for control of inositol in alopecia areata
Skin Research and Technology · 2024
DOI: 10.1111/srt.13800 ↗At a glance
Journal article in Skin Research and Technology, 2024. Written by Ahmed Ibrahim AbdElneam and 4 co-authors. Institution: Department of Clinical Biochemistry, Department of Basic Medical Sciences, College of Medicine, Shaqra University, Dawadmi, Saudi Arabia. Major MEDLINE topics: Alopecia Areata, MicroRNAs, Inositol. Cited 4 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
MicroRNAs (miRNAs) are small RNA molecules that play a regulatory role in various biological processes by acting as intracellular mediators. They hold great potential as therapeutic agents for targeting human disease pathways; however, there is still much to be uncovered about their mechanism of gene regulation. Alopecia areata (AA) is a commonly occurring inflammatory condition characterized by the infiltration of T cells that specifically target the anagen‐stage hair follicle. The limited understanding of its precise cellular mechanism may be the reason behind the scarcity of effective treatments for AA.
Aim
The significance and function of hsa‐miR‐193a‐5p as a genetic marker for AA and its potential influence on the advancement of the disease. Subjects and methods A case‐control study comprised 77 individuals diagnosed with AA who were matched with 75 healthy controls. In order to measure the expression of miR‐200c‐3p in both groups, the real‐time PCR technique was utilized. The prediction of suitable genes for hsa‐miR‐193a‐5p, as well as the identification of pathways and gene‐gene interactions, were carried out using bioinformatic tools.
Results
The levels of hsa‐miR‐193a‐5p expression were notably elevated in AA patients in comparison to healthy controls. Our prediction suggests that the involvement of hsa‐miR‐193a‐5p in the development of AA is significant due to its influence on the inositol phosphorylation pathway and the Phosphatidylinositol signaling system, achieved through its direct impact on the IPPK gene.
Conclusion
For the first time, our study demonstrates the significant over‐expression of a new miRNA, hsa‐miR‐193a‐5p, in the blood of AA patients compared to controls, and highlights its impact on the IPPK gene and the inositol phosphorylation and Phosphatidylinositol signaling pathways, suggesting a potential therapeutic role for hsa‐miR‐193a‐5p in AA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Clinical Biochemistry, Department of Basic Medical Sciences, College of Medicine, Shaqra University, Dawadmi, Saudi Arabia.
- Molecular Genetics and Enzymology Department, Human Genetics and Genome Research Institute, National Research Center, Dokki, Cairo, Egypt.
- Departments of Dermatology, College of Medicine, Shaqra University, Dawadmi, Saudi Arabia.
- Department of Microbiology and Immunology, Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.
- Department of Dermatology, Venereology, and Sexology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
ORCID profiles: Saleh Salem Bahaj
Cite
APA
AbdElneam, A. I., Al-Dhubaibi, M. S., Bahaj, S. S., Mohammed, G. F., & Atef, L. M. (2024). The role of hsa‐miR‐193a‐5p as an important factor for control of inositol in alopecia areata. Skin Research and Technology. https://doi.org/10.1111/srt.13800
Vancouver
AbdElneam AI, Al-Dhubaibi MS, Bahaj SS, Mohammed GF, Atef LM. The role of hsa‐miR‐193a‐5p as an important factor for control of inositol in alopecia areata. Skin Research and Technology. 2024. doi:10.1111/srt.13800
BibTeX
@article{AbdElneam2024,
author = {AbdElneam, Ahmed Ibrahim and Al-Dhubaibi, Mohammed Saleh and Bahaj, Saleh Salem and Mohammed, Ghada Farouk and Atef, Lina Mohammed},
title = {The role of hsa‐miR‐193a‐5p as an important factor for control of inositol in alopecia areata},
journal = {Skin Research and Technology},
year = {2024},
doi = {10.1111/srt.13800}
}
EUVIMED